Fellowship · Portland, OR
Sponsored by Oregon Health & Science University (OHSU Health)
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.
Hepatology (Baltimore, Md.) · 2023 · 1,671 citations · Janice Jou
Aspirin for Metabolic Dysfunction-Associated Steatotic Liver Disease Without Cirrhosis: A Randomized Clinical Trial.
JAMA · 2024 · 81 citations · Robert Wilechansky
Incidence and outcomes of acute kidney injury including hepatorenal syndrome in hospitalized patients with cirrhosis in the US.
Journal of hepatology · 2023 · 81 citations · Robert Wilechansky
Nonalcoholic Fatty Liver Disease and Recent Guideline Updates.
Clinical liver disease · 2021 · 122 citations · Janice Jou
AAV integration in human hepatocytes.
Molecular therapy : the journal of the American Society of Gene Therapy · 2021 · 113 citations · Willscott Naugler
Liver Injury Increases the Incidence of HCC following AAV Gene Therapy in Mice.
Molecular therapy : the journal of the American Society of Gene Therapy · 2021 · 90 citations · Willscott Naugler
The novel SALT-M score predicts 1-year post-transplant mortality in patients with severe acute-on-chronic liver failure.
Journal of hepatology · 2023 · 41 citations · Janice Jou
Liver Stiffness Measurement and Risk Prediction of Hepatocellular Carcinoma After HCV Eradication in Veterans With Cirrhosis.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2024 · 26 citations · Janice Jou